In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
2017 · Nature · 1,101 citations
https://doi.org/10.1038/nature23270
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
4.5K
Citations
9
h-index
9
i10-index
Margaret D. Zimmer is an academic researcher from Cornell University. The author has contributed to research in topics: RNA Research and Splicing & CRISPR and Genetic Engineering & CAR-T cell therapy research. The author has an h-index of 9, co-authored 13 publications.
ORCID: 0000-0002-3317-6569https://doi.org/10.1038/nature23270
https://doi.org/10.1016/j.immuni.2021.01.001
Click to start Chat